Kidney diseases and tissue engineering

Kyung Hyun Moon, In Kap Ko, James J. Yoo, Anthony Atala

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Kidney disease is a worldwide public health problem. Renal failure follows several disease stages including acute and chronic kidney symptoms. Acute kidney injury (AKI) may lead to chronic kidney disease (CKD), which can progress to end-stage renal disease (ESRD) with a mortality rate. Current treatment options are limited to dialysis and kidney transplantation; however, problems such as donor organ shortage, graft failure and numerous complications remain a concern. To address this issue, cell-based approaches using tissue engineering (TE) and regenerative medicine (RM) may provide attractive approaches to replace the damaged kidney cells with functional renal specific cells, leading to restoration of normal kidney functions. While development of renal tissue engineering is in a steady state due to the complex composition and highly regulated functionality of the kidney, cell therapy using stem cells and primary kidney cells has demonstrated promising therapeutic outcomes in terms of restoration of renal functions in AKI and CKD. In this review, basic components needed for successful renal kidney engineering are discussed, and recent TE and RM approaches to treatment of specific kidney diseases will be presented.

Original languageEnglish (US)
JournalMethods
DOIs
StateAccepted/In press - Feb 10 2015
Externally publishedYes

Fingerprint

Kidney Diseases
Tissue Engineering
Tissue engineering
Kidney
Restoration
Regenerative Medicine
Chronic Renal Insufficiency
Dialysis
Acute Kidney Injury
Public health
Medical problems
Stem cells
Grafts
Cell- and Tissue-Based Therapy
Kidney Transplantation
Chronic Kidney Failure
Renal Insufficiency
Chemical analysis
Stem Cells
Therapeutics

Keywords

  • 3D kidney constructs
  • Acute and chronic kidney disease
  • ESRD
  • Kidney disease
  • Tissue engineering
  • Whole kidney engineering

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Moon, K. H., Ko, I. K., Yoo, J. J., & Atala, A. (Accepted/In press). Kidney diseases and tissue engineering. Methods. https://doi.org/10.1016/j.ymeth.2015.06.020

Kidney diseases and tissue engineering. / Moon, Kyung Hyun; Ko, In Kap; Yoo, James J.; Atala, Anthony.

In: Methods, 10.02.2015.

Research output: Contribution to journalArticle

Moon, Kyung Hyun ; Ko, In Kap ; Yoo, James J. ; Atala, Anthony. / Kidney diseases and tissue engineering. In: Methods. 2015.
@article{2a3a1d0fedaa4f78a7ef1ea0eeee96d8,
title = "Kidney diseases and tissue engineering",
abstract = "Kidney disease is a worldwide public health problem. Renal failure follows several disease stages including acute and chronic kidney symptoms. Acute kidney injury (AKI) may lead to chronic kidney disease (CKD), which can progress to end-stage renal disease (ESRD) with a mortality rate. Current treatment options are limited to dialysis and kidney transplantation; however, problems such as donor organ shortage, graft failure and numerous complications remain a concern. To address this issue, cell-based approaches using tissue engineering (TE) and regenerative medicine (RM) may provide attractive approaches to replace the damaged kidney cells with functional renal specific cells, leading to restoration of normal kidney functions. While development of renal tissue engineering is in a steady state due to the complex composition and highly regulated functionality of the kidney, cell therapy using stem cells and primary kidney cells has demonstrated promising therapeutic outcomes in terms of restoration of renal functions in AKI and CKD. In this review, basic components needed for successful renal kidney engineering are discussed, and recent TE and RM approaches to treatment of specific kidney diseases will be presented.",
keywords = "3D kidney constructs, Acute and chronic kidney disease, ESRD, Kidney disease, Tissue engineering, Whole kidney engineering",
author = "Moon, {Kyung Hyun} and Ko, {In Kap} and Yoo, {James J.} and Anthony Atala",
year = "2015",
month = "2",
day = "10",
doi = "10.1016/j.ymeth.2015.06.020",
language = "English (US)",
journal = "Methods in Enzymology",
issn = "0076-6879",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Kidney diseases and tissue engineering

AU - Moon, Kyung Hyun

AU - Ko, In Kap

AU - Yoo, James J.

AU - Atala, Anthony

PY - 2015/2/10

Y1 - 2015/2/10

N2 - Kidney disease is a worldwide public health problem. Renal failure follows several disease stages including acute and chronic kidney symptoms. Acute kidney injury (AKI) may lead to chronic kidney disease (CKD), which can progress to end-stage renal disease (ESRD) with a mortality rate. Current treatment options are limited to dialysis and kidney transplantation; however, problems such as donor organ shortage, graft failure and numerous complications remain a concern. To address this issue, cell-based approaches using tissue engineering (TE) and regenerative medicine (RM) may provide attractive approaches to replace the damaged kidney cells with functional renal specific cells, leading to restoration of normal kidney functions. While development of renal tissue engineering is in a steady state due to the complex composition and highly regulated functionality of the kidney, cell therapy using stem cells and primary kidney cells has demonstrated promising therapeutic outcomes in terms of restoration of renal functions in AKI and CKD. In this review, basic components needed for successful renal kidney engineering are discussed, and recent TE and RM approaches to treatment of specific kidney diseases will be presented.

AB - Kidney disease is a worldwide public health problem. Renal failure follows several disease stages including acute and chronic kidney symptoms. Acute kidney injury (AKI) may lead to chronic kidney disease (CKD), which can progress to end-stage renal disease (ESRD) with a mortality rate. Current treatment options are limited to dialysis and kidney transplantation; however, problems such as donor organ shortage, graft failure and numerous complications remain a concern. To address this issue, cell-based approaches using tissue engineering (TE) and regenerative medicine (RM) may provide attractive approaches to replace the damaged kidney cells with functional renal specific cells, leading to restoration of normal kidney functions. While development of renal tissue engineering is in a steady state due to the complex composition and highly regulated functionality of the kidney, cell therapy using stem cells and primary kidney cells has demonstrated promising therapeutic outcomes in terms of restoration of renal functions in AKI and CKD. In this review, basic components needed for successful renal kidney engineering are discussed, and recent TE and RM approaches to treatment of specific kidney diseases will be presented.

KW - 3D kidney constructs

KW - Acute and chronic kidney disease

KW - ESRD

KW - Kidney disease

KW - Tissue engineering

KW - Whole kidney engineering

UR - http://www.scopus.com/inward/record.url?scp=84945581369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945581369&partnerID=8YFLogxK

U2 - 10.1016/j.ymeth.2015.06.020

DO - 10.1016/j.ymeth.2015.06.020

M3 - Article

JO - Methods in Enzymology

JF - Methods in Enzymology

SN - 0076-6879

ER -